Company Data
Chemomab Therapeutics Ltd.
Ticker
CMMB
Current Price
$2.22 -5.93%
Market Cap
$11.5M
Price Target
Refer to Report
Volume
39.5K
52wk Range
$2.36 - $9.84
Overview
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company’s lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.